Rwanda’s swift response to the recent Marburg virus outbreak highlights the crucial role small organizations can play in combating infectious diseases. Amy Finan, head of the US-based Sabin Vaccine Institute, recounts the rapid mobilization effort that saw her organization provide experimental vaccines to frontline healthcare workers in Rwanda.
A Surprise Call, A Global Response
While on vacation, Finan received a call from Rwanda regarding a potential Marburg outbreak. The virus, similar to Ebola, poses a serious threat with no approved vaccine or antiviral treatment. Finan immediately engaged with the Rwandan government, initiating a daily dialogue focused on containing the outbreak and minimizing casualties.
Lightning-Fast Vaccine Deployment
Within ten days of Rwanda’s public announcement, Sabin had shipped approximately 1,700 doses of its experimental Marburg vaccine to the country. This swift action was made possible by pre-existing partnerships, readily available vaccines, and existing trial data that supported Rwanda’s immunization plan.
Controlling the Outbreak
Rwanda’s robust healthcare system played a crucial role in containing the outbreak. The country implemented strict infection control measures and bolstered critical care facilities. As of October 24, 64 cases and 15 deaths have been reported, making it one of the largest Marburg outbreaks but also one of the least lethal, with a case fatality rate significantly lower than previous surges.
Unconventional Vaccine Trial
Rwanda opted for a unique approach, vaccinating all high-risk healthcare workers and individuals exposed to confirmed cases, rather than conducting a traditional placebo-controlled trial. This decision prioritizes immediate protection over gathering definitive efficacy data. While researchers won’t know for sure if the vaccine prevents infection, they will monitor safety and immune response.
A Model for Future Outbreaks?
Finan emphasizes that Sabin’s rapid response demonstrates the significant impact small organizations can have in tackling infectious disease outbreaks. Strong partnerships, trust among stakeholders, and decisive action are key to effectively combating global health threats.
Stay informed about emerging infectious diseases and support organizations like Sabin Vaccine Institute working tirelessly to protect global health.